We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

288 hedge funds and large institutions have $3.14B invested in Prestige Consumer Healthcare in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 96 increasing their positions, 107 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

91% more call options, than puts

Call options by funds: $153K | Put options by funds: $80K

52% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 25

8% more capital invested

Capital invested by funds: $2.91B → $3.14B (+$221M)

4% more funds holding

Funds holding: 278288 (+10)

0.42% more ownership

Funds ownership: 102.81%103.22% (+0.42%)

10% less repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 107

Holders
288
Holders Change
+10
Holders Change %
+3.6%
% of All Funds
4.19%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
38
Increased
96
Reduced
107
Closed
25
Calls
$153K
Puts
$80K
Net Calls
+$73K
Net Calls Change
-$99K

PBH Hedge Fund Activity: Q4 2023 in Review

288 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2023, worth a combined $3.14B — up 7.6% from $2.91B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new PBH positions and 25 closed out — a net gain of 13 holders — while 96 added to existing stakes and 107 trimmed.

The largest buyer was Congress Asset Management, adding an estimated $34.5M. The largest seller was Dimensional Fund Advisors, cutting an estimated $10M.

  • 288 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2023, up from 278 in Q3 2023.
  • Funds reported $3.14B of Prestige Consumer Healthcare stock for Q4 2023, up 7.6% quarter-over-quarter.
  • 38 funds opened new Prestige Consumer Healthcare positions in Q4 2023 and 25 closed out, a net change of +13 holders.
  • The largest Prestige Consumer Healthcare buyer in Q4 2023 was Congress Asset Management, an estimated $34.5M added.
  • The largest Prestige Consumer Healthcare seller in Q4 2023 was Dimensional Fund Advisors, an estimated $10M sold.

Based on aggregated 13F filings for Q4 2023.